Compounds > 4-carboxy-3-hydroxyphenylglycine
Page last updated: 2024-10-21

4-carboxy-3-hydroxyphenylglycine and Anterior Choroidal Artery Infarction

4-carboxy-3-hydroxyphenylglycine has been researched along with Anterior Choroidal Artery Infarction in 1 studies

4-carboxy-3-hydroxyphenylglycine: weak agonist at metabotropic glutamate receptors; occludes the action of 1-aminocyclopentyl-1,3-dicarboxylate in hippocampus

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rauca, C1
Henrich-Noack, P1
Schäfer, K1
Höllt, V1
Reymann, KG1

Other Studies

1 other study available for 4-carboxy-3-hydroxyphenylglycine and Anterior Choroidal Artery Infarction

ArticleYear
(S)-4C3HPG reduces infarct size after focal cerebral ischemia.
    Neuropharmacology, 1998, Volume: 37, Issue:12

    Topics: Animals; Cerebral Infarction; Cerebral Ventricles; Glycine; Injections, Intraventricular; Ischemic A

1998